Skin drug treatments may regress dangerous birthmarks and prevent melanoma
BOSTON – About one in 20,000 infants is born with what’s called a congenital giant nevus—a huge, pigmented mole that may cover much of the face and body.
Cancer in the News
Feature Articles
The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer
A pharmacologist by training, Dr. Hurlbert is a visionary leader who brings more than 20 years of experience advancing medical research and public health. He has led medical and scientific research programs in the areas of prevention and treatment strategies for breast cancer, lymphoma and multiple myeloma, as well as juvenile diabetes.
Posted in Melanoma News, Patients, Latest News
Michael Postow, MD, on Number of Doses of Immunotherapy in Advanced Melanoma
Advanced melanoma patients who show a favorable response after two doses of nivolumab plus ipilimumab may be spared the standard third and fourth doses of immunotherapy, a study suggested.
Posted in Melanoma News, Health Professionals, Of Interest
Manning Net: guest speaker raises awareness for melanoma
The next Manning Net gathering is being held at Wingham Services Club on Thursday, May 26.
Posted in Melanoma News, Patients, Patient Stories
 |
 |
 |
 |
